Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate advances bill to require Medicaid coverage of FDA‑approved gene therapies for sickle cell disease
Summary
The Connecticut Senate moved and passed legislation requiring Medicaid (Husky) coverage of FDA‑approved gene therapies for sickle cell disease after supporters described the treatments as potentially curative and opponents expressed cost questions. Advocates urged timely access for eligible patients.
The Connecticut Senate passed legislation intended to ensure that people enrolled in the Husky Medicaid program can receive FDA‑approved gene therapies to treat sickle cell disease.
Senator Lesser moved acceptance of the joint committee's favorable report and urged passage, saying the bill would provide access to “essential, life‑saving treatments” for many Husky enrollees who have sickle cell disease. He described the newer…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
